This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

Neurostimulation Devices Market

Neurostimulation Devices Market to Expand at Double Digit CAGR Through 2025; Technological Advancements Boost Market Growth

Neurostimulation Devises Market Segmented By Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Strimulation, Vagus Nerve Stimulation, Cochlear Implants, Gastric Electric Stimulation Implantable Devices and Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation External Devices

- Table of Content -

Chapter 1. Preface11

    1.1. Report Description11

    1.2. Research Methodology12

    1.3. Assumptions13

Chapter 2. Market Synopsis14

Chapter 3. Porter’s Five Forces Analysis16

    3.1. Bargaining Power of Suppliers16

    3.2. Bargaining Power of Buyers17

    3.3. Threat of New Entrants17

    3.4. Threat of Substitutes17

    3.5. Intensity of Rivalry18

Chapter 4. Industry Overview19

    4.1. Market Definition19

    4.2. Market Drivers20

        4.2.1. Increasing prevalence of chronic pain20

        4.2.2. Rise in incidence of neurological disorders21

        4.2.3. Rising awareness about mental diseases and their treatment21

        4.2.4. Growing aging population22

        4.2.5. Increasing R&D investments in novel and innovative neurostimulation devices developments23

        4.2.6. Increasing demand for minimally invasive treatment24

    4.3. Impact Analysis of Market Drivers25

    4.4. Market Restraints26

        4.4.1. Availability of alternative treatment therapies for neurological diseases26

        4.4.2. Side-effects of neurostimulation devices26

    4.5. Impact Analysis of Market Restraints27

    4.6. Opportunities27

        4.6.1. Emerging markets hold major potential27

Chapter 5. Global Market Size and Forecast28

Chapter 6. Market Size and Forecast, by Device Type39

    6.1. Implantable device39

    6.2. External devices41

Chapter 7. Market Size and Forecast, by Implantable Devices44

    7.1. Spinal Cord Stimulation44

    7.2. Deep Brain Stimulation46

    7.3. Sacral Nerve Strimulation48

    7.4. Vagus Nerve Stimulation50

    7.5. Cochlear Implants52

    7.6. Gastric Electric Stimulation54

Chapter 8. Market Size and Forecast, by External Devices57

    8.1. Transcutaneous Electrical Nerve Stimulation57

    8.2. Transcranial Magnetic Stimulation59

Chapter 9. Market Size and Forecast, by Application62

    9.1. Pain Management62

    9.2. Parkinson’s Disease64

    9.3. Urinary and Fecal Incontinence66

    9.4. Epilepsy68

    9.5. Hearing loss70

    9.6. Gastroparesis72

    9.7. Depression74

Chapter 10. Market Size and Forecast, by Geography77

    10.1. North America77

    10.2. Europe80

    10.3. Asia Pacific83

    10.4. Rest of the World (RoW)85

Chapter 11. Competitive Scenario88

    11.1. Competitive Benchmarking88

Chapter 12. Company Profiles91

    12.1. Medtronic plc91

        12.1.1. Company overview91

        12.1.2. Products and services92

        12.1.3. Financial performance93

        12.1.4. Key developments93

    12.2. St. Jude Medical, Inc.94

        12.2.1. Company overview94

        12.2.2. Products and services94

        12.2.3. Financial performance95

        12.2.4. Key developments95

    12.3. Boston Scientific Corporation96

        12.3.1. Company overview96

        12.3.2. Products and services97

        12.3.3. Financial performance98

        12.3.4. Key developments98

    12.4. Cyberonics, Inc.99

        12.4.1. Company overview99

        12.4.2. Products and services99

        12.4.3. Financial performance100

        12.4.4. Key developments100

    12.5. Cochlear, Ltd.101

        12.5.1. Company overview101

        12.5.2. Products and services101

        12.5.3. Financial performance102

        12.5.4. Key developments102

    12.6. NeuroPace, Inc.103

        12.6.1. Company overview103

        12.6.2. Products and services103

        12.6.3. Financial performance103

        12.6.4. Key developments104

    12.7. NeuroSigma, Inc.105

        12.7.1. Company overview105

        12.7.2. Products and services105

        12.7.3. Financial performance105

        12.7.4. Key developments106

    12.8. NDI Medical, LLC107

        12.8.1. Company overview107

        12.8.2. Products and services107

        12.8.3. Financial performance107

        12.8.4. Key developments108

    12.9. MED-EL109

        12.9.1. Company overview109

        12.9.2. Products and services109

        12.9.3. Financial performance110

        12.9.4. Key developments110

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

- List Of Table -

List of Tables

TABLE 1: Market snapshot: Neurostimulation devices market, 2014 and 202014

TABLE 2: Drivers for neurostimulation devices market: Impact analysis25

TABLE 3: Restraints for neurostimulation devices market: Impact analysis27

TABLE 4: Global neurostimulation devices market size, by region, 2010 – 2013 (USD million)29

TABLE 5: Global neurostimulation devices market size, by region, 2014 – 2020 (USD million)29

TABLE 6: Global neurostimulation devices market size, by type of devices, 2010 – 2013 (USD million)30

TABLE 7: Global neurostimulation devices market size, by type of device, 2014 – 2020 (USD million)31

TABLE 8: Global neurostimulation devices market, by implantable devices, 2010 – 2013 (USD million)32

TABLE 9: Global neurostimulation devices market, by implantable devices, 2014 – 2020 (USD million)33

TABLE 10: Global neurostimulation devices market, by external devices, 2010 – 2013 (USD million)34

TABLE 11: Global neurostimulation devices market, by external device type, 2014 – 2020 (USD million)35

TABLE 12: Global neurostimulation devices market, by application type, 2010 – 2013 (USD million)37

TABLE 13: Global neurostimulation devices market, by application type, 2014 – 2020 (USD million)38

TABLE 14: Global implantable device market size, by region, 2010 – 2013 (USD million)40

TABLE 15: Global implantable devices market size, by region, 2014 – 2020 (USD million)41

TABLE 16: Global external devices market size, by region, 2010 – 2013 (USD million)42

TABLE 17: Global external devices market size, by region, 2014 – 2020 (USD million)43

TABLE 18: Global SCS market size, by region, 2010 – 2013 (USD million)45

TABLE 19: Global SCS market size, by region, 2014 – 2020 (USD million)45

TABLE 20: Global DBS market size, by region, 2010 – 2013 (USD million)47

TABLE 21: Global DBS market size, by region, 2014 – 2020 (USD million)48

TABLE 22: Global SNS market size, by region, 2010 – 2013 (USD million)49

TABLE 23: Global SNS market size, by region, 2014 – 2020 (USD million)50

TABLE 24: Global VNS market size, by region, 2010 – 2013 (USD million)51

TABLE 25: Global VNS market size, by region, 2014 – 2020 (USD million)52

TABLE 26: Global CI market size, by region, 2010 – 2013 (USD million)53

TABLE 27: Global CI market size, by region, 2014 – 2020 (USD million)54

TABLE 28: Global GES market size, by region, 2010 – 2013 (USD million)55

TABLE 29: Global GES market size, by region, 2014 – 2020 (USD million)56

TABLE 30: Global TENS market size, by region, 2010 – 2013 (USD million)58

TABLE 31: Global TENS market size, by region, 2014 – 2020 (USD million)58

TABLE 32: Global TMS market size, by region, 2010 – 2013 (USD million )60

TABLE 33: Global TMS market size, by region, 2014 – 2020 (USD million)60

TABLE 34: Global pain management market size, by region, 2010 – 2013 (USD )63

TABLE 35: Global pain management market size, by region, 2014 – 2020 (USD million)64

TABLE 36: Global Parkinson’s disease market size, by region, 2010 – 2013 (USD million)65

TABLE 37: Global Parkinson’s disease market size, by region, 2014 – 2020 (USD million)66

TABLE 38: Global urinary and fecal incontinence market size, by region, 2010 – 2013 (USD million)67

TABLE 39: Global urinary and fecal incontinence market size, by region, 2014 – 2020 (USD million)68

TABLE 40: Global epilepsy market size, by region, 2010 – 2013 (USD million)69

TABLE 41: Global epilepsy market size, by region, 2014 – 2020 (USD million)70

TABLE 42: Global hearing loss market size, by region, 2010 – 2013 (USD million)71

TABLE 43: Global hearing loss market size, by region, 2014 – 2020 (USD million)72

TABLE 44: Global gastroparesis market size, by region, 2010 – 2013 (USD million)73

TABLE 45: Global gastroparesis market size, by region, 2014 – 2020 (USD million)74

TABLE 46: Global depression market size, by region, 2010 – 2013 (USD million)75

TABLE 47: Global depression market size, by region, 2014 – 2020 (USD million)76

TABLE 48: North America neurostimulation devices market size, by country, 2010 – 2013 (USD million)79

TABLE 49: North America neurostimulation devices market size, by country, 2014 – 2020 (USD million)80

TABLE 50: Europe neurostimulation devices market size, by country, 2010 – 2013 (USD million)82

TABLE 51: Europe neurostimulation devices market size, by country, 2014 – 2020 (USD million)82

TABLE 52: Asia Pacific neurostimulation devices market size, by country, 2010 – 2013 (USD million)84

TABLE 53: Asia Pacific neurostimulation devices market size, by country, 2014 – 2020 (USD million)85

TABLE 54: RoW neurostimulation devices market size, by country, 2010 – 2013 (USD million)86

TABLE 55: RoW neurostimulation devices market size, by country, 2014 – 2020 (USD million)87

TABLE 56: Product categories of Medtronic plc92

TABLE 57: Product categories of St. Jude Medical, Inc94

TABLE 58: Product categories of Boston Scientific Corporation97

TABLE 59: Product categories of Cyberonics, Inc99

TABLE 60: Product categories of Cochlear, Ltd.101

TABLE 61: Product categories NeuroPace, Inc.103

TABLE 62: Product categories of NeuroSigma, Inc.105

TABLE 63: Product categories of NDI Medical, LLC107

TABLE 64: Product categories of MED-EL109

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

- List Of Chart -

List of Figures

FIG. 1: Neurostimulation devices market: Porter’s five forces analysis16

FIG. 2: Aging population in major countries, 2000 – 2050 (% share of total population)23

FIG. 3: Global neurostimulation devices market share, by region, by value, 201328

FIG. 4: Global neurostimulation devices market share, by type of devices, by value, 201330

FIG. 5: Global neurostimulation devices market share, by implantable devices, by value, 201331

FIG. 6: Global neurostimulation devices market share, by external devices, by value, 201334

FIG. 7: Global neurostimulation devices market share, by application type, by value, 201336

FIG. 8: Global implantable device market share, by region, by value, 201339

FIG. 9: Global external devices market share, by region, by value, 201342

FIG. 10: Global SCS market share, by region, by value 201344

FIG. 11: Global DBS market, by region 2013 (% share)47

FIG. 12: Global SNS market share, by region, by value 201349

FIG. 13: Global VNS market share, by region, by value, 2013 (% share)51

FIG. 14: Global CI market share, by region, by value, 2013 (% share)53

FIG. 15: Global GES market share, by region, by value, 2013 (% share)55

FIG. 16: Global TENS market share, by region, by value, 2013 (% share)57

FIG. 17: Global TMS market share, by region, by value, 201359

FIG. 18: Global pain management market share, by region, by value, 201362

FIG. 19: Global Parkinson’s disease market share, by region, by value, 201365

FIG. 20: Global urinary and fecal incontinence market share, by region, by value, 201367

FIG. 21: Global epilepsy market share, by region, by value, 201369

FIG. 22: Global hearing loss market share, by region, by value, 201371

FIG. 23: Global gastroparesis market share, by region, by value, 201373

FIG. 24: Global depression market share, by region, by value, 201375

FIG. 25: North America neurostimulation devices market share, by country, by value, 2013 (% share)79

FIG. 26: Europea neurostimulation devices market share, by country, by value, 2013 (% share)81

FIG. 27: Asia Pacific neurostimulation devices market share, by country, by value, 2013 (% share)84

FIG. 28: RoW neurostimulation devices market share, by country, by value, 2013 (% share)86

FIG. 29: Leading players and their product offerings in the market88

FIG. 30: Overall market presence and focus on neurostimulation business89

FIG. 31: Sales and net earnings of Medtronic, plc, 2012 – 2014 (USD Million)93

FIG. 32: Net sales and net earnings of St. Jude Medical, Inc, 2011 – 2013 (USD Million)95

FIG. 33: Net sales and net income/loss of Boston Scientific Corporation, 2011 – 2013 (USD Million)98

FIG. 34: Net sales and net income of Cyberonics, Inc, 2011 – 2013 (USD Million)100

FIG. 35: Revenue and net profit of Cochlear, Ltd., 2011 – 2013 (USD million)102

Google translate